A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans

Thalidomide is increasingly being used as adjuvant therapy for patients with mycobacterial and human immunodeficiency virus (HIV) infections. The T-helper (Th)1 cytokine–Th2 cytokine balance critically determines the outcomes of these diseases. To obtain insight into the effect of thalidomide on the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Verbon, Annelies, Juffermans, Nicole P., Speelman, Peter, van Deventer, Sander J. H., ten Berge, Ineke J. M., Guchelaar, Henk-Jan, van der Poll, Tom
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2000
Aiheet:
Biologic Response Modifiers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC90059/
https://ncbi.nlm.nih.gov/pubmed/10952569
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia